Follow Us On

Facebook  X  Linkedin  YouTube
 
 
 




Medicare’s Efficiency Cut: A Surgical Strike on Physician Pay





Medicare just rewrote the math on how America pays for surgery. Starting January 1, 2026, thousands of procedures and outpatient services will be reimbursed at lower rates under a new rule the agency calls an “efficiency adjustment.” On paper, it is a modernization effort. In reality, it is a direct challenge to the physician groups that have dictated pricing for decades.


For years, the Relative Value Scale Update Committee, known as the RUC, has shaped how physician services are valued. Critics say that process rewarded procedures over time-based care. Each surgical innovation, new device, or complex code came with higher payment assumptions, even as technology made those procedures faster, safer, and less costly to perform. The system rewarded complexity, not efficiency.


CMS says that ends in 2026. The new rule assumes that advances in technology and standardized workflows have reduced the real work and expense behind thousands of procedures. Payments for those services will be reduced by 2.5 percent. Office visits, behavioral health therapy, telehealth services, and maternity care are exempt.


Click here to read the full article.

On October 31, 2025, the CMS issued a Final Rule that announces final policy changes for Medicare payments under the Physician Fee Schedule and other Medicare Part B issues effective on or after January 1, 2026. 


Even though we have submitted numerous comments (ASIPP’s detailed comment letter), letters, and congressional requests, CMS has not made any changes in the Final Rule compared to the proposed rule. There are numerous misinterpretations, consequently resulting in errors to the payments. 


PHYSICIAN PAYMENTS

Conversion Factor 

  • Beginning in January 2026, there will be two separate conversion factors (CF): one for qualifying alternative payment model (APM) participants (QPs) and one for physicians and practitioners who are not QPs. 
  • In 2026, the CF will be $33.57 for QPs and $33.40 for non-QPs. These amounts represent increases of 3.8% and 3.3%, respectively, compared to the 2025 CF of $32.35.
  • The CF update is primarily based on three factors:
  1. A statutory update in the Medicare Access and CHIP Reauthorization Act that provides a 0.25% CF increase for non-QPs and 0.75% increase for QPs
  2. A 0.49% budget neutrality adjustment increase
  3. A one-time 2.5% increase due to the budget reconciliation legislation 


Efficiency Adjustment

CMS finalized its proposal to apply an efficiency adjustment to non-time-based codes and services. As such, the agency will apply a negative 2.5% reduction to the work relative value unit (RVU) and the corresponding intraservice portion of physician time for non-time-based services. The efficiency adjustment will not apply to evaluation and management, care management, behavioral health, new codes, and any services on the Medicare Telehealth Services List.


Modifications to Indirect Practice Expense Methodology

CMS finalized its proposal to revise the methodology for allocating indirect practice expense (PE) costs for facility-based services by reducing the portion of facility PE RVUs by half the amount allocated to non-facility-based services. Previously, allocation was equal in both settings.


Indirect practice costs include expenses such as rent, administrative staff, scheduling, and billing and coding. CMS cites stakeholder concerns that paying both the physician and the facility for the same indirect costs may result in duplicative payment.

This shift in resources from facility to non-facility practices shifts reimbursement from one to the other. Non-facility practices will experience an increase in reimbursement while hospital-based practices will see a decrease in reimbursement.


Specialty Impact

As a result of these sweeping methodology reforms, on average, the interventional pain management specialty will experience a payment differential based on the physician’s practice setting. 

  • Physicians that practice in a facility setting (hospitals and ASCs) will see a reimbursement decrease of approximately 11%. 
  • Physicians in independent practices and office settings will see a reimbursement increase of approximately 7% to 10% for services provided in office settings, including procedures and E/M services. 
  • Unfortunately, for independent physicians providing services in ASCs, which is mistakenly considered as a facility as ASCs do not provide any benefits for practice expenses, there will be reimbursement decreases of 8% to 11% for any services provided in ASCs.


Telehealth

CMS finalized most telehealth policies as proposed:

  • Streamlined Telehealth Services List: CMS will simplify the process for adding services to the list by removing the “provisional” and “permanent” distinction and focusing the review solely on whether the service can be effectively delivered via two-way audio-video. 
  • Removal of Frequency Limitations: Frequency limits for subsequent inpatient, subsequent nursing facility, and critical care consultation telehealth services will no longer be in place. 
  • Permanent Virtual Direct Supervision: For services requiring direct supervision, CMS will permanently allow this supervision to occur through real-time audio and visual interactive telecommunications (not audio-only). 


The agency did revise the provision on the teaching physician policy and will allow teaching physicians to have a virtual presence in all teaching settings, in clinical instances when the service was furnished virtually, on a permanent basis.


Quality Payment Program (QPP)

CMS’ proposed rule limited changes to QPP in an attempt to provide stability to the program. As such, CMS finalized its proposal to keep the Merit-Based Incentive Payment System (MIPS) performance threshold at 75 points through the 2028 performance period/2030 MIPS payment year.


Ambulatory Specialty Model (ASM)

CMS has proposed the Ambulatory Specialty Model (ASM) to hold specialists financially accountable for managing chronic conditions in Original Medicare, focusing on low back pain and congestive heart failure. The model begins January 1, 2027, and runs through 2031, with payment adjustments starting in 2029.


Specialists—including anesthesiology, pain management, neurosurgery, orthopedics, and PM&R—would face payment adjustments from –9% to +9%, based on performance in disease management, adherence to clinical guidelines, and care coordination. However, CMS plans to use a “redistribution percentage” of 85%, ensuring Medicare savings by reducing total physician payments, unlike MIPS or the Hospital VBP program.


CMS refused to make any changes to Ambulatory Service Model for low back pain management as we have requested. 


Summary of CMS Payment Rules 

This summary highlights the good, bad and the ugly.

Good:

  • Conversion factor increase of 3.6% to 3.8%.
  • Payment increases of approximately 10% for office procedures and 7%–10% for evaluation and management (E/M) services.
  • 2.6% payment increase for Ambulatory Surgery Center (ASC) services.

Bad:

  • No permanent extension of telehealth services, despite multiple established rules. However, our sources indicate telehealth is included.
  • A 2.5% efficiency adjustment applied to work RVUs for non-time-based services.

Ugly:

  • 8%–10% reductions in physician payments for services provided in hospitals or ASCs. Our sources indicate telehealth is included.


In addition, physicians continue to face increasing administrative burdens, including preauthorizations, expanding Medicare regulations through LCDs (which are adopted by Medicare Advantage Plans, Medicaid, and incorporated into private medical policies), and frequent audits. At any given time, approximately 30% of interventional pain physicians are under audit. This has resulted in significant time spent on documentation, preauthorizations, and adherence to the appropriateness criteria set by LCDs and medical policies.


This is not a realistic assessment, given that physician payments have already decreased by 33% since 2001. The situation is further compounded by an ever-growing number of rules, regulations, and administrative burdens associated with EMRs—and now AI. Physician workload continues to rise, not fall. Remember the concept of “pajama time,” as many physicians work late into the evening to complete their documentation.

  • The proposed conversion factor increase is only a temporary measure and may be clawed back, similar to the post-COVID cuts that followed payment increases under the Trump Administration.
  • ASCs are being grouped with hospitals, despite being overwhelmingly owned and operated by independent physicians.
  • ASCs essentially function as extensions of office practices.
  • Independent physicians providing services at hospitals and ASCs are inaccurately classified as hospital-based physicians. 


ASIPP will be providing you with additional analysis and is considering providing a webinar to highlight the key changes in 2026 Physician Fee Schedule for interventional pain management community. 


2026 Fee Schedules

Medicare Prices to Drop Up to 85% on Drugs for Weight Loss, Cancer, Psoriasis, and More

New prices for enrollees will start in 2027



Medicare beneficiaries will save as much as 85% off the list price when negotiated prices for 15 blockbuster drugs go into effect in 2027, the Centers for Medicare & Medicaid Services (CMS) said Tuesday.


In 2024, Medicare would have saved $8.5 billion in net covered prescription drug costs -- about 36% less net spending -- if the negotiated prices had been in effect, CMS said in a fact sheet. Drugs on the list include household names such as semaglutide (Ozempic, Rybelsus, Wegovy), palbociclib (Ibrance), and linaclotide (Linzess). The negotiated prices are up to 85% less than the list price. In 2024, about 5.3 million people with Medicare Part D coverage used these drugs to treat a variety of conditions, such as cancer, type 2 diabetes, and asthma, CMS said.


Also in 2024, people with Medicare Part D prescription drug coverage spent $1.7 billion out of pocket for the negotiated drugs. When the discounts go into effect in 2027, beneficiaries will save an estimated $685 million in out-of-pocket costs that year, according to CMS.


Click here to read the full article.

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


Click here to apply.

No additional cost for ASIPP members!

Upcoming ASIPP Webinars

Register today!

Join ASIPP on January 17, 2026, for an important webinar: Unveiling the Complexities of Controlled Substance Management in Interventional Pain Management (IPM).


Controlled substance management continues to present challenges for pain physicians, from evolving regulations and compliance requirements to balancing patient care with risk mitigation. This webinar will provide expert guidance to help you navigate these complexities and strengthen your practice.

Join ASIPP on January 31, 2026, for our webinar Strategies for Successful Practice Management. This program will focus on practical approaches to strengthen your practice through improved documentation, compliance strategies, and effective practice-building techniques.


Whether you are looking to optimize workflows, ensure regulatory readiness, or position your practice for long-term growth, this webinar will provide valuable insights to support your success.



Where ACA benchmark premiums are rising the most in 2026




Arkansas will see the largest percentage increase in average ACA benchmark premiums between 2025 and 2026, while Alaska is the only state where the average benchmark premium will decline, according to KFF.


The U.S. average increase is 26%. Premiums were analyzed using the second-lowest-cost silver (benchmark) premium for a 40-year-old in each county and weighted by county plan selections.


States ranked by percentage change in average benchmark premiums from 2025 to 2026:

  1. Arkansas: 69%
  2. Washington: 41%
  3. Tennessee: 38%
  4. Mississippi: 37%
  5. Illinois: 36%
  6. Texas: 35%
  7. Kentucky: 34%
  8. Florida: 33%
  9. Kansas: 31%
  10. Arizona: 30%


Click here to read the full article.

This webinar is designed to help pain medicine fellows and early-career physicians navigate the job search. Speakers will break down the pros and cons of key practice types—solo, academic, private group, and corporate-owned—so you can make informed career decisions. The session concludes with a live Q&A, giving you the opportunity to get clear answers to your most important questions.

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.




How Introverted Doctors Can Better Connect With Patients




Whether you consider yourself an introvert or an extrovert — or a bit of both — your personality likely influenced your choice of medical specialty. It also affects how you practice medicine and interact with your colleagues and patients. At its heart, practicing medicine is about connection — with not only your patients but also your healthcare colleagues as well. Extroverted doctors have an easier time expressing their emotions, which can enhance their bedside manner. Introverted docs may give off an impression of being disconnected or standoffish when in fact they’re simply less outgoing.


So, do extroverted physicians have an advantage when it comes to connecting with patients — and can introverted docs learn to be more extroverted at work?


Medicine May Attract Introverts

While definitions of introversion vary, introverts are considered more self-reflective and less outgoing than extroverts, who are more social, active, and talkative . According to a Medscape report, nearly 4 in 10 (38%) of doctors identify as an “even mix of introvert and extrovert,” while more than 35% tend toward introversion and 28% identify as extroverts.


Click here to read the full article.

A limited number of qualifying residents/fellows will receive a scholarship to attend the ASIPP 28th Annual Meeting, March 19-21, 2026 at the Hilton New Orleans Riverside. Recipients of this scholarship with receive reimbursement of their meeting registration, and up to three nights stay at the host hotel. This includes room block rate and tax.


Deadline to apply is February 15, 2026.


Click here for more information.

Join Us in New Orleans for ASIPP 2026

Earn CMEs, Expand Networks, and Explore the Future of Pain Management

It is our pleasure to invite you to the American Society of Interventional Pain Physicians’ 2026 Annual Meeting, where we will continue to shape the future of Interventional Pain Management.


This 28th Annual Meeting will take place Thursday, March 19 through Saturday, March 21, 2026, at the Hilton New Orleans Riverside in New Orleans, Louisiana.


The 2026 Annual Meeting will provide the tools, knowledge, and connections you need to thrive in the evolving field of interventional pain management.

JOIN or RENEW your ASIPP Membership for the best registration rates.




Medicare Advantage Just Won a 13 Billion Dollar Boost 




For the past year I have brought you nothing but bad news about the Medicare Advantage program. Collapsing networks. Worsening SNF approvals. Observation status chaos. Star rating crashes. Lawsuits. Overpayment scandals. But today the news breaks in the opposite direction. Medicare Advantage plans are set to receive an enormous financial lift worth thirteen point two billion dollars between 2028 and 2036 under changes released by the Centers for Medicare and Medicaid Services.


The agency is eliminating a dozen administrative quality measures and restoring a reward system that increases ratings when plans improve year over year. Most seniors will never hear about these changes and most agents will never understand why they matter. But the people who do understand are Medicare Advantage insurers, because this decision injects billions of bonus dollars back into their operations. These bonus dollars directly fund richer supplemental benefits, zero premium plan expansion, and far more aggressive marketing in every state.


This happens at the same time that MedPAC reports Medicare Advantage is already paid at one hundred twenty two percent of the cost of traditional Medicare. It also happens during ongoing Justice Department and Inspector General investigations into risk score gaming, chart reviews, and upcoding. While CMS has spent the past two years publicly talking about reining in Medicare Advantage overpayments, the rule change moves in the opposite direction and restores the very mechanism that originally inflated star ratings before two thousand twenty four.


Click here to read the full article.

Our Sponsor

Our Sponsor


What to Know About the H3N2 Flu Strain That Has Experts Concerned

The U.S. may be in for yet another rough flu season



The U.S. may be in for yet another rough flu season, particularly as influenza A H3N2 mutated into a new subclade and has been associated with an earlier-than-usual start to flu season in other parts of the world.


H3N2 picked up about seven new mutations in its hemagglutinin protein -- which enables it to attach to receptors on human cells -- as it spread through the Southern Hemisphere late this summer, which is far more than the one or two needed to evade prior immunity, said Pedro Piedra, MD, a pediatric infectious diseases physician at Baylor College of Medicine and Texas Children's Hospital in Houston.


"Last year, we had one of the most severe influenza seasons that we've had for many years. In part, it was driven by H3N2," Piedra told MedPage Today. "This year, chances are that it will be equally as severe, again driven by H3N2."


Click here to read the full article.


Apply now!



December 13, 2025

January 24 & February 7, 2026



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam

Exam Dates



Could SGLT2 Inhibitors Reduce Rheumatoid Arthritis Flares?



Two real-world analyses presented at the American College of Rheumatology Convergence 2025 revived an important clinical question for rheumatologists and endocrinologists: Can medications developed for type 2 diabetes also modulate articular inflammation?


“We are seeing the boundary between metabolism and inflammation dissolve in practice,” said Licia Maria Henrique da Mota, MD, PhD, professor of rheumatology at the Department of Rheumatology, University of Brasília, Brasília, Brazil. “These findings reinforce the hypothesis that the immunometabolic axis is not theoretical. It has clinical implications, particularly in rheumatoid arthritis, obesity, and metabolic syndrome.”


Marcelo de Medeiros Pinheiro, MD, PhD, associate professor of rheumatology at the Federal University of São Paulo in São Paulo, Brazil, said, “The results are provocative. They suggested that drugs originally developed for metabolic diseases may exert anti-inflammatory effects. But we need pragmatic trials to separate metabolic effects from immunological effects.”


Click here to read the full article.

 

We're excited to let you know that the new ASIPP Community, hosted by DocMatter, is now live!


The ASIPP Community on DocMatter will serve as a place for members to collaborate around clinical and research topics to advance the care of their interventional pain patients.


Click here to be a part of the conversation!

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

A Case Study of Yoga-Controlled Symptom Remission in Fibromyalgia Syndrome: A Holistic Approach


Garima Sharma, MD, Samreen Fatima, MSc, Avany Sathyan, MD, Akanksha Singh, MD, Raj Kumar Yadav, MD, Uma Kumar, MD, and Renu Bhatia, MD

Use of Stellate Ganglion Block in the Treatment of Postural Orthostatic Tachycardia Syndrome: A Novel Case Report


Michael Suarez, DO, Laura Ibidunni, MD, David S. Jevotovsky, MD, Harman Chopra, MD, and Bryan J. Marascalchi, MD

 
 

New Issue Now Available

 

SYSTEMATIC REVIEWS

Management of Chronic Post-Herniorrhaphy Pain: A Systematic Review


Gema Ruiz Lopez del Prado, MD, PhD, Antonio Ferreiro, MD, PhD, and Martin Avellanal, MD, PhD

Efficacy of Ultrasound-Guided Pulsed Radiofrequency in the Management of Pain Caused by Knee Osteoarthritis: A Systematic Review and Meta-Analysis


Shifeng Lai, MM, Huimin Li, MBBS, Jinlian Li, MM, Yu Ma, MBBS, Na Luo, MBBS, Min Xu, MBBS, Ping Liu, MBBS, Hongping Zhang, MBBS, and Qinglan He, MBBS




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!